1191411-58-1

Basic information

• Product Name: 4-[(Cyclopentyl{4-[(5-oxo-2-phenyl-5,6-dihydro-4H-1,3,4-oxadiazin-4-yl)methyl]phenyl}-acetyl)amino]-2-methyl-2,3-dihydro-1H-indene-2-carboxylic acid
• Synonyms: 4-[(Cyclopentyl{4-[(5-oxo-2-phenyl-5,6-dihydro-4H-1,3,4-oxadiazin-4-yl)methyl]phenyl}-acetyl)amino]-2-methyl-2,3-dihydro-1H-indene-2-carboxylic acid
• CAS NO: 1191411-58-1
• Molecular Weight: 565.669
• Mol File: 1191411-58-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[(Cyclopentyl{4-[(5-oxo-2-phenyl-5,6-dihydro-4H-1,3,4-oxadiazin-4-yl)methyl]phenyl}-acetyl)amino]-2-methyl-2,3-dihydro-1H-indene-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(Cyclopentyl{4-[(5-oxo-2-phenyl-5,6-dihydro-4H-1,3,4-oxadiazin-4-yl)methyl]phenyl}-acetyl)amino]-2-methyl-2,3-dihydro-1H-indene-2-carboxylic acid(1191411-58-1)
• EPA Substance Registry System: 4-[(Cyclopentyl{4-[(5-oxo-2-phenyl-5,6-dihydro-4H-1,3,4-oxadiazin-4-yl)methyl]phenyl}-acetyl)amino]-2-methyl-2,3-dihydro-1H-indene-2-carboxylic acid(1191411-58-1)

Safety Data

• Hazardous Substances Data: 1191411-58-1(Hazardous Substances Data)

Upstream product

• 1191413-20-3 methyl 4-amino-2-methyl-2,3-dihydro-1H-indene-2-carboxylate 
• 1191413-19-0 methyl 4-(benzylamino)-2-methyl-2,3-dihydro-1H-indene-2-carboxylate 
• 1191413-18-9 Methyl 2-methyl-4-{[(trifluoromethyl)sulfonyl]oxy}-2,3-dihydro-1H-indene-2-carboxylate 
• 1191413-17-8 methyl 4-hydroxy-2-methyl-2,3-dihydro-1H-indene-2-carboxylate 
• 379257-40-6 ethyl 4-methoxy-2,3-dihydro-1H-indene-2-carboxylate 
• 379257-42-8 ethyl 4-methoxy-2-methylindan-2-carboxylate 
• 1191413-53-2 Methyl 4-[(cyclopentyl{4-[(5-oxo-2-phenyl-5,6-dihydro-4H-1,3,4-oxadiazin-4-yl)methyl]-phenyl}acetyl)amino]-2-methyl-2,3-dihydro-1H-indene-2-carboxylate 

Relevant articles and documents

OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF

The present application relates to novel carboxylic acid derivatives having an oxo-substituted azaheterocyclic partial structure, processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prevention of cardiovascular disorders.